Insider Transactions in Q4 2020 at Novo Cure LTD (NVCR)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Ely Benaim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,484
-4.02%
|
$387,504
$156.71 P/Share
|
|
Dec 21
2020
|
Ely Benaim Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,484
+3.84%
|
$161,460
$65.43 P/Share
|
|
Dec 18
2020
|
Asaf Danziger |
SELL
Open market or private sale
|
Direct |
207,910
-3.55%
|
$33,265,600
$160.5 P/Share
|
|
Dec 18
2020
|
Asaf Danziger |
BUY
Exercise of conversion of derivative security
|
Direct |
207,910
+25.63%
|
$4,574,020
$22.0 P/Share
|
|
Dec 18
2020
|
Jeryl L Hilleman |
SELL
Open market or private sale
|
Direct |
2,500
-42.37%
|
$415,000
$166.4 P/Share
|
|
Nov 02
2020
|
Ashley Cordova Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
230
-0.87%
|
$26,910
$117.41 P/Share
|
|
Oct 29
2020
|
Pritesh Shah Chief Growth Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,468
+11.13%
|
$335,148
$11.1 P/Share
|